RxDoctor Payments Data

Corazon Alvarado

Adult Health · Fort Payne, ALNPI 1083775183

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.7% of the total across 214 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by OPKO Pharmaceuticals, LLC at 38.7% of the total. Reporting peaked in 2021 at $676 and has fallen 96.7% since, to $22 in 2025.

$2,030in general payments, 2019–2025

Across 214 payments — averaging $9.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • OPKO Pharmaceuticals, LLC$785
  • Merck$253
  • Novo Nordisk$239
  • Lilly USA, LLC$178
  • Amgen$104
  • Bayer$102
  • plus $367 from 11 others

What the payments were for

  • Food & beverage$1,90394%
  • Education$1276%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,030 in reported general payments places this provider in the 70th percentile of 308 adult health providers in Alabama.

See all adult health providers in Alabama →

Other adult health in Fort Payne

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →